Echosens and Boehringer Ingelheim have expanded their collaboration aimed at expediting progress in metabolic ...

This expansion will change the trajectory of MASH by focusing on early detection, diagnosis, and access to care.

Targeting PDE4 drives anti-inflammatory and antifibrotic effects, and Boehringer has been working on its own PDE4 inhibitor ...

Boehringer Ingelheim & Eko Health ink digital health collaboration to improve heart murmur detection in dogs: Ingelheim, Germany Wednesday, June 11, 2025, 10:00 Hrs [IST] Boehring ...

In a pharmaphorum podcast recorded onsite at the Congress, web editor Nicole Raleigh spoke with Itziar Canamasas, global head ...

Korea's Beringer Ingelheim recently held an event for executives and employees '60 seconds to show kidney health' As part of ...

Biopharmaceutical company Boehringer Ingelheim is using data and more to drive organizational change and has outlined four ...

By combining their diagnostic and therapeutic expertise, Echosens and Boehringer Ingelheim aim to help close persistent gaps ...

Ingelheim: Boehringer Ingelheim and Eko Health have entered a strategic collaboration agreement to improve heart murmur ...

A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to ...